Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Soochow UniversityNo recent work listed

Lian Lian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8620-0374; OpenAlex author ID A5101746407. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. Efficacy of relative dose intensity of nab-paclitaxel for the short-term outcomes, survival, and quality of life in patients with advanced pancreatic cancer: a… Co-author DOI 10.21037/tcr-22-1604↗
  2. Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresect… Co-author DOI 10.18632/oncotarget.21340↗
  3. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. Co-author DOI 10.18632/oncotarget.9975↗
  4. FH535 inhibited metastasis and growth of pancreatic cancer cells. Co-author DOI 10.2147/ott.s82718↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei Li · 3 shared papers, 2015–2017 · strength 0.16
  2. Meng Shen · 3 shared papers, 2015–2017 · strength 0.16
  3. Min Tao · 3 shared papers, 2015–2017 · strength 0.16
  4. Chong Zhou · 1 shared paper, 2022 · strength 0.16
  5. Dapeng Li · 1 shared paper, 2022 · strength 0.16
  6. Qiaoming Zhi · 2 shared papers, 2016–2017 · strength 0.11
  7. Mengyao Wu · 2 shared papers, 2015–2017 · strength 0.11
  8. Weiming Duan · 2 shared papers, 2015–2016 · strength 0.10
  9. Kai Chen · 2 shared papers, 2015–2016 · strength 0.10
  10. Xiaojie Bian · 1 shared paper, 2017 · strength 0.06
  11. Yuan Hong Gao · 1 shared paper, 2017 · strength 0.06
  12. Lu Liu · 1 shared paper, 2016 · strength 0.05
  13. Mengyao Wu · 1 shared paper, 2016 · strength 0.05
  14. Daoming Li · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.